NASDAQ:CHFS - CHF Solutions Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $3.44 -0.05 (-1.43 %) (As of 05/22/2019 04:00 PM ET)Previous Close$3.4874Today's Range$3.33 - $3.5052-Week Range$3.15 - $44.10Volume52,397 shsAverage Volume158,525 shsMarket Capitalization$7.80 millionP/E RatioN/ADividend YieldN/ABeta2.65 ProfileAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email CHF Solutions, Inc., a medical device company, focuses on the provision of solutions for patients suffering from fluid overload. The company's commercial product is the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. Its Aquadex FlexFlow system includes a console, and disposable blood set and catheter. The company sells its products to hospitals and clinics through its direct Salesforce in the United States; and through independent specialty distributors primarily in Brazil, Germany, Hong Kong, India, Italy, Singapore, Spain, Thailand, and the United Kingdom. The company was formerly known as Sunshine Heart, Inc. and changed its name to CHF Solutions, Inc. in May 2017. CHF Solutions, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota. Receive CHFS News and Ratings via Email Sign-up to receive the latest news and ratings for CHFS and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:CHFS Previous SymbolNASDAQ:SSH CUSIPN/A CIK1506492 Webhttp://www.chf-solutions.com/ Phone952-345-4200Debt Debt-to-Equity Ratio0.03 Current Ratio5.86 Quick Ratio2.28Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$5 million Price / Sales1.56 Cash FlowN/A Price / Cash FlowN/A Book Value$5.52 per share Price / Book0.62Profitability EPS (Most Recent Fiscal Year)($42.14) Net Income$-17,030,000.00 Net Margins-336.26% Return on Equity-188.60% Return on Assets-148.57%Miscellaneous Employees55 Outstanding Shares2,268,000Market Cap$7.80 million Next Earnings Date8/6/2019 (Estimated) OptionableNot Optionable CHF Solutions (NASDAQ:CHFS) Frequently Asked Questions What is CHF Solutions' stock symbol? CHF Solutions trades on the NASDAQ under the ticker symbol "CHFS." When did CHF Solutions' stock split? How did CHF Solutions' stock split work? CHF Solutions's stock reverse split on Friday, October 13th 2017. The 1-20 reverse split was announced on Thursday, October 12th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 12th 2017. An investor that had 100 shares of CHF Solutions stock prior to the reverse split would have 5 shares after the split. How were CHF Solutions' earnings last quarter? CHF Solutions Inc (NASDAQ:CHFS) announced its quarterly earnings results on Tuesday, May, 7th. The company reported ($11.47) EPS for the quarter, missing the consensus estimate of ($1.42) by $10.05. The company earned $1.22 million during the quarter. CHF Solutions had a negative net margin of 336.26% and a negative return on equity of 188.60%. View CHF Solutions' Earnings History. When is CHF Solutions' next earnings date? CHF Solutions is scheduled to release their next quarterly earnings announcement on Tuesday, August 6th 2019. View Earnings Estimates for CHF Solutions. What price target have analysts set for CHFS? 1 equities research analysts have issued 1-year price targets for CHF Solutions' shares. Their predictions range from $3.30 to $3.30. On average, they anticipate CHF Solutions' stock price to reach $3.30 in the next twelve months. This suggests that the stock has a possible downside of 4.1%. View Analyst Price Targets for CHF Solutions. What is the consensus analysts' recommendation for CHF Solutions? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CHF Solutions in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CHF Solutions. Has CHF Solutions been receiving favorable news coverage? Media stories about CHFS stock have been trending somewhat positive on Wednesday, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. CHF Solutions earned a media sentiment score of 1.7 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 8.0 out of 10, meaning that recent press coverage is very likely to have an impact on the stock's share price in the near future. Who are some of CHF Solutions' key competitors? Some companies that are related to CHF Solutions include Viveve Medical (VIVE), Precision Optics (PEYE), Digirad (DRAD), Fc Global Realty (FCRE), ENDRA Life Sciences (NDRA), Non-Invasive Monitoring Systems (NIMU), Aradigm (ARDM), Vaso (VASO), Nexeon Medsystems (NXNN), Reshape Lifesciences (RSLS), Escalon Medical (ESMC), Trimedyne (TMED), SpectraScience (SCIE), Guided Therapeutics (GTHP) and Newcardio (NWCI). What other stocks do shareholders of CHF Solutions own? Based on aggregate information from My MarketBeat watchlists, some companies that other CHF Solutions investors own include IMMUTEP LTD/S (IMMP), Inovio Pharmaceuticals (INO), Melinta Therapeutics (MLNT), Catalyst Pharmaceuticals (CPRX), CytRx (CYTR), Genocea Biosciences (GNCA), Idera Pharmaceuticals (idra), La Jolla Pharmaceutical (LJPC), Nektar Therapeutics (NKTR) and Tonix Pharmaceuticals (TNXP). Who are CHF Solutions' key executives? CHF Solutions' management team includes the folowing people: Mr. John L. Erb, Chairman, CEO & Pres (Age 70)Ms. Claudia Napal Drayton, Chief Financial Officer (Age 51)Mr. Vitaliy Epshteyn, Sr. VP of Operations & Engineering (Age 41)Mr. David Lerner, Sr. VP of Corp. Devel. & TechnologyMr. Thomas P. Lynch, VP, Gen. Counsel, Chief Compliance Officer & Sec. (Age 52) Who are CHF Solutions' major shareholders? CHF Solutions' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Perkins Capital Management Inc. (17.32%), Renaissance Technologies LLC (8.05%) and Virtu Financial LLC (2.76%). Company insiders that own CHF Solutions stock include Gregory D Waller, John L Erb and Ki Yong Choi. View Institutional Ownership Trends for CHF Solutions. Which institutional investors are buying CHF Solutions stock? CHFS stock was bought by a variety of institutional investors in the last quarter, including Perkins Capital Management Inc., Renaissance Technologies LLC and Virtu Financial LLC. Company insiders that have bought CHF Solutions stock in the last two years include John L Erb and Ki Yong Choi. View Insider Buying and Selling for CHF Solutions. How do I buy shares of CHF Solutions? Shares of CHFS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is CHF Solutions' stock price today? One share of CHFS stock can currently be purchased for approximately $3.44. How big of a company is CHF Solutions? CHF Solutions has a market capitalization of $7.80 million and generates $5 million in revenue each year. The company earns $-17,030,000.00 in net income (profit) each year or ($42.14) on an earnings per share basis. CHF Solutions employs 55 workers across the globe. What is CHF Solutions' official website? The official website for CHF Solutions is http://www.chf-solutions.com/. How can I contact CHF Solutions? CHF Solutions' mailing address is 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN, 55344. The company can be reached via phone at 952-345-4200 or via email at [email protected] MarketBeat Community Rating for CHF Solutions (NASDAQ CHFS)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 237 (Vote Outperform)Underperform Votes: 187 (Vote Underperform)Total Votes: 424MarketBeat's community ratings are surveys of what our community members think about CHF Solutions and other stocks. Vote "Outperform" if you believe CHFS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHFS will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/22/2019 by MarketBeat.com StaffFeatured Article: Can systematic risk be avoided? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.